Ghost Tree Capital, LLC Cogent Biosciences, Inc. Transaction History

Ghost Tree Capital, LLC

$310 Million
Q1 2024

A detailed history of Ghost Tree Capital, LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 450,000 shares of COGT stock, worth $3.79 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

450,000

Previous 195,000 130.77%

Holding current value

$3.79 Million

Previous $1.15 Million 163.87%

% of portfolio

0.98%

Previous 0.42%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.38 - $9.02 $1.12 Million - $2.3 Million	255,000 Added 130.77%	450,000 $3.02 Million
Q4 2023 Feb 14, 2024	SELL	$4.06 - $10.08 $1.85 Million - $4.59 Million	-455,000 Reduced 70.0%	195,000 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$9.69 - $13.34 $726,750 - $1 Million	75,000 Added 13.04%	650,000 $6.34 Million
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.24 $246,250 - $331,000	25,000 Added 4.55%	575,000 $6.81 Million
Q1 2023 May 15, 2023	SELL	$10.04 - $15.5 $2.51 Million - $3.88 Million	-250,000 Reduced 31.25%	550,000 $5.93 Million

Q4 2022 Feb 14, 2023	BUY	$10.65 - $14.84 $2.13 Million - $2.97 Million	200,000 Added 33.33%	800,000 $9.25 Million
Q3 2022 Nov 14, 2022	SELL	$9.39 - $16.99 $2.82 Million - $5.1 Million	-300,000 Reduced 33.33%	600,000 $8.95 Million
Q2 2022 Aug 15, 2022	SELL	$3.92 - $9.73 $3.14 Million - $7.78 Million	-800,000 Reduced 47.06%	900,000 $8.12 Million
Q4 2021 Feb 16, 2022	BUY	$7.51 - $10.81 $1.5 Million - $2.16 Million	200,000 Added 13.33%	1,700,000 $14.6 Million
Q3 2021 Nov 15, 2021	SELL	$5.99 - $9.14 $599,000 - $914,000	-100,000 Reduced 6.25%	1,500,000 $12.6 Million
Q1 2021 May 14, 2021	BUY	$7.47 - $12.34 $3.74 Million - $6.17 Million	500,000 Added 45.45%	1,600,000 $14 Million
Q4 2020 Feb 16, 2021	BUY	$9.04 - $13.01 $9.94 Million - $14.3 Million	1,100,000 New	1,100,000 $12.4 Million

Others Institutions Holding COGT

# of Institutions

159

Shares Held

102M

Call Options Held

197K

Put Options Held

102K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $554M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account

Ghost Tree Capital, LLC Cogent Biosciences, Inc. Transaction History